Content intended for healthcare professionals. By continuing, you confirm you are a HCP.
US reimbursement
Trabecular Bone Score® is reimbursed in the US under four dedicated CPT® Category I codes, billable alongside DXA. Here's how it works.
Original Medicare routinely reimburses TBS® procedures. Coverage may vary by payer, plan, and region.
Overview
The first reimbursable CPT® codes for Trabecular Bone Score® became effective in the USA on 1 January 2022, a significant step forward in osteoporosis care. TBS® benefits from four dedicated CPT® Category I codes, priced by CMS under the Physician Fee Schedule and the Outpatient Prospective Payment System (OPPS).
Based on recent Medicare claims data, TBS® utilisation in the US has approximately doubled each year since 2022.
The codes
CPT CODE
DESCRIPTION
77089
TBS® structural condition of bone microarchitecture; using DXA or other imaging data on gray-scale variogram, calculation, with interpretation and report on fracture risk
77090
TBS®; technical preparation and transmission of data for analysis to be performed elsewhere
77091
TBS®; technical calculation only
77092
TBS®; interpretation and report on fracture risk only, by other qualified health care professional
The AMA standard
The AMA reserves Category I codes for procedures meeting strict criteria for clinical acceptance and efficacy. TBS® satisfies all of them:
✓
FDA-cleared device: The devices needed to perform the procedure have FDA clearance or approval
✓
Widely performed: Carried out by many qualified US healthcare professionals
✓
High volume: Frequently performed in line with its intended clinical use
✓
Standard of care: Consistent with current medical practice
✓
Evidence-based: clinical efficacy documented in literature meeting CPT® application requirements
FAQ
Reimbursement resource
TBS Osteo™ is intended exclusively for healthcare professionals and is not available for purchase by the general public. TBS Osteo is a Class IIa medical device, CE marked under EU MDR 2017/745 (CE 2460). TBS Osteo is FDA 510(k) cleared (K243218) for use in the United States. TBS Osteo is included on the Australian Register of Therapeutic Goods (ARTG No. 528950) as "Inovanz Pty Ltd — X-ray system, diagnostic, general-purpose, application program software". Manufacturer: Medimaps Group SA, Chemin du Champ-des-Filles 36A, 1228 Plan-les-Ouates, Geneva, Switzerland. Always follow the instructions for use.